☰

Maggie C. Louie, Ph.D. - Publications

Affiliations: 
2004 University of California, Davis, Davis, CA 
Area:
Molecular Biology, Cell Biology, Biochemistry
Tree Info Grants Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Magbanua MJM, Brown-Swigart L, Hirst G, Yau C, Wolf D, Wu H, Tin A, Shchegrova S, Sethi H, Salari R, Aleshin A, Louie M, Zimmermann B, DeMichele A, Liu M, et al. Abstract P5-01-04: Personalized monitoring of circulating tumor DNA during neoadjuvant therapy in high-risk early stage breast cancer reflects response and risk of metastatic recurrence Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P5-01-04  0.364
2019 Ginn E, Baek J, Zou H, Fallatah MMJ, Liu S, Sevigny MB, Louie M. Enantiomer of the novel flexible heteroarotinoid, SL-1-09, blocks cell cycle progression in breast cancer cells. European Journal of Pharmacology. 172634. PMID 31494077 DOI: 10.1016/J.Ejphar.2019.172634  0.517
2019 Bloomfield M, Louie MC. Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα. Scientific Reports. 9: 12135. PMID 31431634 DOI: 10.1038/S41598-019-46912-3  0.532
2019 Coombes C, Page K, Salari R, Hastings RK, Armstrong AC, Ahmed S, Ali S, Cleator SJ, Kenny LM, Stebbing J, Rutherford MJ, Sethi H, Boydell AR, Swenerton R, Fernandez-Garcia D, ... ... Louie MC, et al. Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30992300 DOI: 10.1158/1078-0432.Ccr-18-3663  0.445
2019 Zou H, Sevigny MB, Liu S, Madden DT, Louie MC. Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2. Cancer Letters. 443: 157-166. PMID 30503556 DOI: 10.1016/J.Canlet.2018.11.022  0.531
2019 Magbanua M, Brown-Swigart L, Hirst G, Yau C, Wolf D, Ma A, Bergin E, Venters S, Sethi H, Wu H, Salari R, Tin T, Sawyer S, Louie M, Zimmermann B, et al. Abstract PD2-01: Personalized serial circulating tumor DNA (ctDNA) analysis in high-risk early stage breast cancer patients to monitor and predict response to neoadjuvant therapy and outcome in the I-SPY 2 TRIAL Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Pd2-01  0.393
2019 Coombes R, Armstrong AC, Ahmed S, Page K, Hastings R, Salari R, Sethi H, Boydell A, Shchegrova S, Fernandez-Garcia D, Gleason K, Goddard K, Guttery D, Assaf Z, Balcioglu M, ... ... Louie M, et al. Abstract P4-01-02: Early detection of residual breast cancer through a robust, scalable and personalized analysis of circulating tumour DNA (ctDNA) antedates overt metastatic recurrence Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-01-02  0.437
2017 Louie MC, Sevigny MB. Steroid hormone receptors as prognostic markers in breast cancer. American Journal of Cancer Research. 7: 1617-1636. PMID 28861319  0.436
2017 Fallatah M, Liu S, Sevigny MB, Zou H, Louie MC. Novel flexible heteroarotinoid, SL-1-18, promotes ERα degradation to inhibit breast cancer cell growth. Cancer Letters. PMID 28844711 DOI: 10.1016/J.Canlet.2017.08.026  0.535
2017 Zou H, Ginn E, Francis SM, Liu S, Louie M. Abstract 2090: Targeting estrogen receptor negative breast cancer cells using diarylthiourea analogs of SHetA2 Cancer Research. 77: 2090-2090. DOI: 10.1158/1538-7445.Am2017-2090  0.539
2017 Ginn E, Zou H, Fallatah MM, Liu S, Louie MC. Abstract 113: Evaluating the anticancer activity of two flexible heteroarotinoid analogs on breast cancer Cancer Research. 77: 113-113. DOI: 10.1158/1538-7445.Am2017-113  0.452
2016 Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, et al. Corrigendum: ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nature Medicine. 22: 692. PMID 27270780 DOI: 10.1038/Nm0616-692B  0.538
2016 Wang J, Zou JX, Xue X, Cai D, Zhang Y, Duan Z, Xiang Q, Yang JC, Louie MC, Borowsky AD, Gao AC, Evans CP, Lam KS, Xu J, Kung HJ, et al. ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer. Nature Medicine. PMID 27019329 DOI: 10.1038/Nm.4070  0.542
2015 Liu S, Louie MC, Rajagopalan V, Zhou G, Ponce E, Nguyen T, Green L. Synthesis and evaluation of the diarylthiourea analogs as novel anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 25: 1301-5. PMID 25701251 DOI: 10.1016/J.Bmcl.2015.01.042  0.464
2015 Ponce E, Louie MC, Sevigny MB. Acute and chronic cadmium exposure promotes E-cadherin degradation in MCF7 breast cancer cells. Molecular Carcinogenesis. 54: 1014-25. PMID 24798214 DOI: 10.1002/Mc.22170  0.422
2015 Fallatah M, Louie MC, Liu S. Abstract 1775: Inhibition of breast cancer cell proliferation by diarylthiourea analog, SL1-18 Cancer Research. 75: 1775-1775. DOI: 10.1158/1538-7445.Am2015-1775  0.504
2015 Nambi D, Louie MC, Liu S. Abstract 1774: The effects of diarylthiourea analogs on triple negative breast cancer cell growth Cancer Research. 75: 1774-1774. DOI: 10.1158/1538-7445.Am2015-1774  0.527
2014 Lubovac-Pilav Z, Borràs DM, Ponce E, Louie MC. Correction: Using expression profiling to understand the effects of chronic cadmium exposure on MCF-7 breast cancer cells (PLoS ONE) Plos One. 9. DOI: 10.1371/annotation/4737b7e4-0d5e-4f86-b916-bda9b6cabd84  0.388
2013 Lubovac-Pilav Z, Borràs DM, Ponce E, Louie MC. Using expression profiling to understand the effects of chronic cadmium exposure on MCF-7 breast cancer cells. Plos One. 8: e84646. PMID 24376830 DOI: 10.1371/Journal.Pone.0084646  0.493
2013 Ponce E, Aquino NB, Louie MC. Chronic cadmium exposure stimulates SDF-1 expression in an ERα dependent manner. Plos One. 8: e72639. PMID 24015267 DOI: 10.1371/Journal.Pone.0072639  0.474
2013 Louie MC, Laim J. Abstract 516: VDR overexpression restores tamoxifen responsiveness. Cancer Research. 73: 516-516. DOI: 10.1158/1538-7445.Am2013-516  0.5
2013 O'Sullivan JK, Helphrey TR, Laim J, Louie MC, Carranza MG. Abstract 2478: Novel tyrosine derivatives of temozolomide active against breast cancer cell lines. Cancer Research. 73: 2478-2478. DOI: 10.1158/1538-7445.Am2013-2478  0.493
2012 Aquino NB, Sevigny MB, Sabangan J, Louie MC. The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not? Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews. 30: 189-224. PMID 22970719 DOI: 10.1080/10590501.2012.705159  0.436
2012 Sevigny MB, Graham K, Ponce E, Louie MC, Mitchell K. Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors. Pharmacological Research. 65: 445-50. PMID 22245433 DOI: 10.1016/J.Phrs.2012.01.001  0.327
2011 Ponce EM, Louie MC. Abstract 3900: Formaldehyde induces DNA damage and BRCA1 nuclear export Cancer Research. 71: 3900-3900. DOI: 10.1158/1538-7445.Am2011-3900  0.437
2010 Siewit CL, Gengler B, Vegas E, Puckett R, Louie MC. Cadmium promotes breast cancer cell proliferation by potentiating the interaction between ERalpha and c-Jun. Molecular Endocrinology (Baltimore, Md.). 24: 981-92. PMID 20219890 DOI: 10.1210/Me.2009-0410  0.508
2010 Louie MC, McClellan A, Siewit C, Kawabata L. Estrogen receptor regulates E2F1 expression to mediate tamoxifen resistance. Molecular Cancer Research : McR. 8: 343-52. PMID 20215421 DOI: 10.1158/1541-7786.Mcr-09-0395  0.409
2009 Chow RY, Siewit CL, Louie MC. Effects of vitamin D on tamoxifen resistant breast cancer cell growth The Faseb Journal. 23. DOI: 10.1096/Fasebj.23.1_Supplement.699.3  0.47
2008 Li LB, Louie MC, Chen HW, Zou JX. Proto-oncogene ACTR/AIB1 promotes cancer cell invasion by up-regulating specific matrix metalloproteinase expression. Cancer Letters. 261: 64-73. PMID 18162290 DOI: 10.1016/J.Canlet.2007.11.013  0.537
2006 Louie MC, Revenko AS, Zou JX, Yao J, Chen HW. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Molecular and Cellular Biology. 26: 3810-23. PMID 16648476 DOI: 10.1128/Mcb.26.10.3810-3823.2006  0.557
2004 Louie MC, Zou JX, Rabinovich A, Chen HW. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Molecular and Cellular Biology. 24: 5157-71. PMID 15169882 DOI: 10.1128/Mcb.24.12.5157-5171.2004  0.635
2004 Lee LF, Louie MC, Desai SJ, Yang J, Chen HW, Evans CP, Kung HJ. Interleukin-8 confers androgen-independent growth and migration of LNCaP: differential effects of tyrosine kinases Src and FAK. Oncogene. 23: 2197-205. PMID 14767470 DOI: 10.1038/Sj.Onc.1207344  0.522
2004 Yang JC, Chang Y, Lee L, Louie M, Desai S, Busby JE, Kung H, Evans CP. 1090: Interleukin-8 Stimulates Androgen-Independent Growth of Androgen Dependent LNCaP Cells Journal of Urology. 171: 287-287. DOI: 10.1016/S0022-5347(18)38327-7  0.329
2003 Louie MC, Yang HQ, Ma AH, Xu W, Zou JX, Kung HJ, Chen HW. Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex. Proceedings of the National Academy of Sciences of the United States of America. 100: 2226-30. PMID 12589022 DOI: 10.1073/Pnas.0437824100  0.487
Show low-probability matches.